Does heart transplantation provide comparable survival in patients with hypertrophic cardiomyopathy compared to those with non-HCM cardiovascular diseases?
Survival after heart transplantation for hypertrophic cardiomyopathy is comparable to or potentially better than survival for other cardiovascular diseases.
HCM patients compose a small subset (1%) of the overall population of patients who undergo heart transplantation in the United States. Nonetheless, survival after transplant among HCM patients is comparable to that of patients transplanted for non-HCM cardiovascular diseases, with possible enhanced survival over time.
Maron et al. (Wed,) studied this question.